HARBOUR EQUINE (08377) announced its interim results, with a loss attributable to shareholders of HK$1.226 million, a year-on-year reversal from profit to loss.
Victoria Harbour Holdings Limited (08377) announced its results for the six months ending June 30, 2026. During this period, the group generated revenue of HKD 10.073 million, a decrease of 39.51% year-on-year; the loss attributable to the parent company's shareholders was HKD 1.226 million, shifting from profit to loss compared to the previous year; the basic loss per share was HKD 0.25.
HARBOUR EQUINE (08377) announced its performance for the six months ended June 30, 2026, during which the group recorded revenue of HK$10.073 million, a decrease of 39.51% year-on-year; the loss attributable to owners of the parent company was HK$1.226 million, shifting from profit to loss year-on-year; basic loss per share was HK$0.25.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





